Healthcare
Vertex Pharmaceuticals to Acquire Alpine Immune Sciences in $4.9 Billion Deal
Acquisition Strengthens Vertex's Position in Immunotherapy and Renal Disease Treatment Vertex Pharmaceuticals (VRTX) and Alpine Immune Sciences, Inc. (Nasdaq: ALPN)...
Advancing Addiction Treatment: Adial Pharmaceuticals’ AD04 Shows Promise in Clinical Study
Peer-Reviewed Article Highlights Safety and Efficacy of Low-Dose Ondansetron in Treating Alcohol Use Disorder Adial Pharmaceuticals (ADIL), a pioneer in...
Moderna’s Cancer Vaccine Shows Positive Results, Shares Surge
Early-Stage Trial Signals Potential Breakthrough in Cancer Treatment Moderna (MRNA) witnessed a significant uptick in its shares, climbing 8% to...
Acrivon Therapeutics Secures $130 Million in Private Financing for Precision Oncology Advancements
Biopharmaceutical Company Raises Capital to Propel Clinical Trials and Innovative Research Acrivon Therapeutics (ACRV), a pioneer in precision oncology medicines,...
Allurion Launches Virtual Care Suite for Obesity Management
Comprehensive Digital Solution Aims to Enhance Patient Outcomes and Clinic Efficiency Allurion Technologies, Inc. has unveiled its Virtual Care Suite...
TC BioPharma Announces Strategic Expansion with NK Cell Therapeutics
Acquisition of CAR-NK Assets to Bolster Cancer Therapy Portfolio TC BioPharm (TCBP), a leading biotechnology company specializing in allogeneic gamma-delta...
Candel Therapeutics Reports Encouraging Survival Data for CAN-2409 in Pancreatic Cancer
Updated Interim Results Show Prolonged Survival and Immune Activation in Borderline Resectable PDAC Patients Candel Therapeutics (CADL), a clinical-stage biopharmaceutical...
Fanapt Receives FDA Approval for Bipolar I Disorder Treatment
Vanda Pharmaceuticals Expands Fanapt Franchise with Novel Indication Vanda Pharmaceuticals (VNDA) has announced a significant milestone as the U.S. Food...
ARCA Biopharma and Oruka Therapeutics Announce Merger to Pave the Way for Advanced Biologic Treatments
Combined Entity Aims to Revolutionize Chronic Skin Disease Treatment with Cutting-Edge Antibodies ARCA biopharma (ABIO) and Oruka Therapeutics have finalized...
Xilio Therapeutics Secures Funding for Clinical Advancement of Cancer Therapies
Strategic Reprioritization and Partnership with Gilead Sciences Propel Xilio's Innovative Oncology Pipeline Xilio Therapeutics (XLO), a leading biotechnology firm specializing...
